Lexicon Pharmaceuticals Inc
LXRX
Market Cap$247.18M
Close$
$-0.39
156.8% downside
Current Fair Value
156.8% downsideOvervalued by 156.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $247.18 Million |
|---|---|
| Enterprise Value | $288.92 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.63 |
| Beta | 1.03 |
| Outstanding Shares | 361,492,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -1.23 |
|---|---|
| PEG | -4.34 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 55.35 |
| Enterprise Value to EBIT | -1.37 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.38 |
| Debt to Equity | 0.74 |
Revenue Sources
No data
Insider Trades
ESG Score
No data